Cresco Labs (CRLBF) Accumulated Expenses (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Accumulated Expenses came in at $55.0 million in Q1 2026, down 1.98% YoY from $56.1 million in Q1 2025, and down 5.14% on a QoQ basis from $58.0 million in Q4 2025.
Cresco Labs (CRLBF) Accumulated Expenses (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Accumulated Expenses data on file, last reported at $55.0 million in Q1 2026.
- Quarterly Accumulated Expenses fell 1.98% year-over-year to $55.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.0 million (down 1.98% YoY) and the FY2025 annual result came in at $58.0 million, up 6.85% from the prior year.
- Accumulated Expenses declined to $55.0 million in Q1 2026, from $58.0 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $96.0 million in Q1 2022 to a low of $50.1 million in Q3 2025.
- A 5-year average of $60.9 million and a median of $56.1 million in 2025 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2024 — Accumulated Expenses fell 21.4% — and 2025, when it climbed 6.85%.
- Tracing CRLBF's Accumulated Expenses over 5 years: stood at $96.0 million in 2022, then decreased by 28.01% to $69.1 million in 2023, then retreated by 21.4% to $54.3 million in 2024, then climbed by 6.85% to $58.0 million in 2025, then fell by 5.14% to $55.0 million in 2026.
- The last three Accumulated Expenses figures came in at $55.0 million (Q1 2026), $58.0 million (Q4 2025), and $50.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.03 Mn |
| Dec 31, 2025 | 58.02 Mn |
| Sep 30, 2025 | 50.09 Mn |
| Jun 30, 2025 | 54.43 Mn |
| Mar 31, 2025 | 56.15 Mn |
| Dec 31, 2024 | 54.30 Mn |
| Sep 30, 2024 | 60.48 Mn |
| Jun 30, 2024 | 54.35 Mn |
| Mar 31, 2024 | 61.92 Mn |
| Dec 31, 2023 | 69.08 Mn |
| Mar 31, 2022 | 95.96 Mn |
| Dec 31, 2021 | 95.44 Mn |
| Sep 30, 2021 | 69.19 Mn |
| Mar 31, 2021 | 110.40 Mn |
| Dec 31, 2020 | 130.47 Mn |